AVTS Aventus Capital Inc.
Aventus Capital Inc. is a private equity and venture capital firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mezzanine, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry including multi-sector holdings and specialized finance sectors. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm is an integrated insurance and alternative asset management company, purpose-built to deliver long-term value across the annuity and investment landscapes. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for 7 to 15 years. Aventus Capital Inc. was founded in 1996 and is based in Toronto, Canada with an additional office in New York, New York.…
Industry Peers
Asset ManagementKey Statistics
About Aventus Capital (CVE: AVTS)
›
Aventus Capital (CVE: AVTS) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Asset Management industry, part of the Financial Services sector.
The shares were at 15.50 CAD on 19 November 2026, down 32.9% over 52 weeks. Its 52-week range is 15.50 CAD to 27.60 CAD, and it trades at the bottom of that range.
Its market capitalisation is 515.29M CAD.
Aventus Capital reports return on equity of -5.8%.
It holds more cash than debt, a net cash position of 363.18M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 29.65 CAD is 91.3% above the current price. The next earnings report is expected on 25 March 2027.